Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Rubello

Showing results (131-140 of 471) with videos related to

Pageof 48
Sort By:
Clinical Nuclear Medicine|July 3, 2013
Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling timeMarina Hodolič, Anna Margherita Maffione, Jure Fettich, et al.
Clinical Nuclear Medicine|December 14, 2011
FDG PET/CT in ovarian cancer: what about treatment response and prognosis?Gaia Grassetto, David Groheux, Maria Cristina Marzola, et al.
Clinical Nuclear Medicine|September 6, 2011
Noninvasive and invasive staging of ovarian cancer: review of the literatureChiara Fuccio, Paolo Castellucci, Maria Cristina Marzola, et al.
Nuclear Medicine Communications|June 8, 2010
Imaging with (11)Carbon labelled PET tracersStefano Fanti, Cristina Nanni, Egesta Lopci, et al.
Clinical Nuclear Medicine|April 2, 2014
18F-FDG PET/CT in tumefactive multiple sclerosisAnna Margherita Maffione, Lucia Rampin, Gaia Grassetto, et al.
European Journal of Radiology|May 23, 2012
Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocolAlice Ferretti, Elena Bellan, Marcello Gava, et al.
Journal of Nuclear Medicine Technology|November 17, 2007
Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body regionArianna Massaro, Silvia Cittadin, Francesca Rossi, et al.
Nuclear Medicine Communications|April 2, 2014
Are PREDIST criteria better than PERCIST criteria as a PET predictor of preoperative treatment response in rectal cancer?Anna Margherita Maffione, Maria Cristina Marzola, Gaia Grassetto, et al.
Clinical Nuclear Medicine|February 6, 2018
False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt LymphomaAnna Margherita Maffione, Lucia Rampin, Paolini Rossella, et al.
Clinical Nuclear Medicine|June 20, 2020
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?Anna Margherita Maffione, Giampaolo Montesi, Paola Caroli, et al.
Pageof 48

Showing results (131-140 of 471) with videos related to

Sort By:
Pageof 48
Clinical Nuclear Medicine|July 3, 2013
Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling timeMarina Hodolič, Anna Margherita Maffione, Jure Fettich, et al.
Clinical Nuclear Medicine|December 14, 2011
FDG PET/CT in ovarian cancer: what about treatment response and prognosis?Gaia Grassetto, David Groheux, Maria Cristina Marzola, et al.
Clinical Nuclear Medicine|September 6, 2011
Noninvasive and invasive staging of ovarian cancer: review of the literatureChiara Fuccio, Paolo Castellucci, Maria Cristina Marzola, et al.
Nuclear Medicine Communications|June 8, 2010
Imaging with (11)Carbon labelled PET tracersStefano Fanti, Cristina Nanni, Egesta Lopci, et al.
Clinical Nuclear Medicine|April 2, 2014
18F-FDG PET/CT in tumefactive multiple sclerosisAnna Margherita Maffione, Lucia Rampin, Gaia Grassetto, et al.
European Journal of Radiology|May 23, 2012
Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocolAlice Ferretti, Elena Bellan, Marcello Gava, et al.
Journal of Nuclear Medicine Technology|November 17, 2007
Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body regionArianna Massaro, Silvia Cittadin, Francesca Rossi, et al.
Nuclear Medicine Communications|April 2, 2014
Are PREDIST criteria better than PERCIST criteria as a PET predictor of preoperative treatment response in rectal cancer?Anna Margherita Maffione, Maria Cristina Marzola, Gaia Grassetto, et al.
Clinical Nuclear Medicine|February 6, 2018
False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt LymphomaAnna Margherita Maffione, Lucia Rampin, Paolini Rossella, et al.
Clinical Nuclear Medicine|June 20, 2020
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?Anna Margherita Maffione, Giampaolo Montesi, Paola Caroli, et al.
Pageof 48